Shaimaa S Ibrahim

Dr. Shaimaa S Ibrahim

Faculty of Pharmacy, Ain Shams University, Cairo, Al Qāhirah, Egypt
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2021 in Neuropharmacology
Verified
Journal Article
Closed access
SIShaimaa S Ibrahim
Shaimaa S Ibrahim
OEOmar G. Abo Elseoud
Omar G. Abo Elseoud
MMMohamed H. Mohamedy
Mohamed H. Mohamedy
MAMohamed M. Amer
Mohamed M. Amer
YMYoussef Y. Mohamed
Youssef Y. Mohamed
MGMina Y. George
Mina Y. George

1 June 2019 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
SIShaimaa S Ibrahim
Shaimaa S Ibrahim

1 August 2022 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
SIShaimaa S Ibrahim
Shaimaa S Ibrahim
HAHend Abd-Allah
Hend Abd-Allah

12 December 2022 in Expert Opinion on Drug Delivery
Verified
Journal Article
Closed access
MGMina Y. George
Mina Y. George
MEMarwa O. El-Derany
Marwa O. El-Derany
YAYasmine Ahmed
Yasmine Ahmed
MZMalvina Zaher
Malvina Zaher
CICaroline Ibrahim
Caroline Ibrahim
SIShaimaa S Ibrahim
Shaimaa S Ibrahim
The present study aims to formulate and evaluate the efficacy of chrysin-loaded nanoemulsion (CH NE) against lithium/pilocarpine-induced epilepsy in rats, as well as, elucidate its effect on main e...

1 March 2009 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
SIShaimaa S Ibrahim
Shaimaa S Ibrahim
GAGehanne A.S. Awad
Gehanne A.S. Awad
AGAhmed Geneidi
Ahmed Geneidi
NMNahed D. Mortada
Nahed D. Mortada

9 June 2015 in Drug Delivery
Verified
Journal Article
Closed access
SIShaimaa S Ibrahim
Shaimaa S Ibrahim
RORihab Osman
Rihab Osman
GAGehanne A. S. Awad
Gehanne A. S. Awad
NMNahed D. Mortada
Nahed D. Mortada
AGAhmed-Shawky Geneidy
Ahmed-Shawky Geneidy
Low molecular weight heparins (LMWHs), the anticoagulant drug of choice in many indications, had been suggested as novel drug treatment for a range of diseases. Their superior pharmacokinetic properties compared to unfractionated heparin (UFH), motivated scientists to explore new delivery systems for improved therapeutic outcomes. Micro- and nano-carriers, with the versatile nature and characteristics of materials used for their fabrication, are able to surmount the challenges opposed by their native structures. The present review discusses the recent perspectives on the development of micro- and nano-particulate vectors for the delivery of LMWHs through various routes. Special focus on the application of the suggested systems, their characterization and the achieved improved bioavailability will be given throughout the review.